Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: Subgroup analysis of CASTOR based on cytogenetic risk

K Weisel, A Spencer, S Lentzsch, H Avet-Loiseau, T M Mark, I Spicka, T Masszi, B Lauri, Mark-David Levin, A Bosi, V Hungria, M Cavo, JJ Lee, A Nooka, H Quach, M Munder, C Lee, W Barreto, P Corradini, CK MinAA Chanan-Khan, N Horvath, M Capra, M Beksac, R Ovilla, J C Jo, HJ Shin, Pieter Sonneveld, T Casneuf, N Deangelis, H Amin, J Ukropec, R Kobos, MV Mateos

Research output: Contribution to journalArticleAcademic

31 Citations (Scopus)
15 Downloads (Pure)
Original languageEnglish
Article number115
JournalJournal of Hematology and Oncology
Issue number1
Publication statusPublished - 2020

Research programs

  • EMC NIHES-02-65-01

Cite this